MedTrace Logo

White Matter in Pediatric Bipolar Disorder: A DTI Study

NCT00391235 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2010-12-06

No results posted yet for this study

Summary

Fourteen subjects with bipolar disorder and 14 matching healthy controls, aged 6-13, will receive a magnetic resonance imaging (MRI) scan on a 3 Tesla scanner. They will also have a clinical interview, including the KSADS-PL. All subjects must be right-handed.

Conditions

Sponsors & Collaborators

  • American Academy of Child Adolescent Psychiatry.

    collaborator OTHER

  • Eli Lilly and Company

    collaborator INDUSTRY

  • Cambridge Health Alliance

    lead OTHER

Principal Investigators

  • Jean A Frazier, MD · Cambridge Health Alliance

Eligibility

Min Age
6 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2008-09-30
Completion
2008-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00391235 on ClinicalTrials.gov